Impact of Captopril on Liver and Tumor Parameters in Experimental Models
40 likes | 169 Vues
This study investigates the effects of Captopril on liver function and tumor growth in various experimental models. Supplementary data include statistical analyses showing significant differences, with p-values of 0.018, 0.033, 0.047, 0.002, and 0.003 among treatment groups including normal liver, control liver, and tumor models. Findings suggest potential protective effects of Captopril on liver health and tumor progression, making it a candidate for further exploration as a therapeutic adjunct. Detailed figures illustrate key comparisons and results.
Impact of Captopril on Liver and Tumor Parameters in Experimental Models
E N D
Presentation Transcript
Supplementary Fig 2 a b *p=0.018 p=0.033 p=0.047 *p=0.013 Normal Liver Control Liver Normal Liver Control Liver Captopril Liver Captopril Liver Control Tumor Control Tumor Captopril Tumor Captopril Tumor
Supplementary Fig 4 a b **p=0.002 **p=0.003 p=0.039*